Cargando…
Low Serum Paraoxonase-1 Activity Associates with Incident Cardiovascular Disease Risk in Subjects with Concurrently High Levels of High-Density Lipoprotein Cholesterol and C-Reactive Protein
Paroxonase-1 (PON1) is a key enzyme that inhibits low-density lipoprotein oxidation and consequently atherogenesis. Here, we assessed whether low serum PON1 activity associates with incident cardiovascular disease (CVD) in subjects with high levels of high-density cholesterol (HDL-C) and C-reactive...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780415/ https://www.ncbi.nlm.nih.gov/pubmed/31480611 http://dx.doi.org/10.3390/jcm8091357 |
_version_ | 1783457135252733952 |
---|---|
author | Corsetti, James P. Sparks, Charles E. James, Richard W. Bakker, Stephan J. L. Dullaart, Robin P. F. |
author_facet | Corsetti, James P. Sparks, Charles E. James, Richard W. Bakker, Stephan J. L. Dullaart, Robin P. F. |
author_sort | Corsetti, James P. |
collection | PubMed |
description | Paroxonase-1 (PON1) is a key enzyme that inhibits low-density lipoprotein oxidation and consequently atherogenesis. Here, we assessed whether low serum PON1 activity associates with incident cardiovascular disease (CVD) in subjects with high levels of high-density cholesterol (HDL-C) and C-reactive protein (CRP), a marker of low-grade systemic inflammation. Cox proportional-hazards modeling of incident CVD risk (11 years mean follow-up) adjusted for relevant clinical and biomarker covariates was performed on a population-based study (N = 7766) stratified into three groups: low CRP—(LR; event rate 4.9%); low HDL-C/high CRP—(HR1; event rate 14.4%); and high HDL-C/high CRP—(HR2; event rate 7.6%). Modeling results for PON1 activity in HR2 were significant and robust (hazard ratio/SD unit—0.68, 95% CI 0.55–0.83, p = 0.0003), but not so for LR and HR1. Analyses in HR2 of the interaction of PON1 with HDL-C, apoA-I, apoA-II, and apoE levels were significant only for PON1 with apoE (hazard ratio—1.77, 95% CI 1.29–2.41, p = 0.0003). Subsequent subgroup analysis revealed inverse risk dependence for apoE at low PON1 levels. In conclusion, in a population-based study of subjects with concurrently high HDL-C and CRP levels, low serum PON1 activity associates with incident CVD risk with risk accentuated at low apoE levels. |
format | Online Article Text |
id | pubmed-6780415 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-67804152019-10-30 Low Serum Paraoxonase-1 Activity Associates with Incident Cardiovascular Disease Risk in Subjects with Concurrently High Levels of High-Density Lipoprotein Cholesterol and C-Reactive Protein Corsetti, James P. Sparks, Charles E. James, Richard W. Bakker, Stephan J. L. Dullaart, Robin P. F. J Clin Med Article Paroxonase-1 (PON1) is a key enzyme that inhibits low-density lipoprotein oxidation and consequently atherogenesis. Here, we assessed whether low serum PON1 activity associates with incident cardiovascular disease (CVD) in subjects with high levels of high-density cholesterol (HDL-C) and C-reactive protein (CRP), a marker of low-grade systemic inflammation. Cox proportional-hazards modeling of incident CVD risk (11 years mean follow-up) adjusted for relevant clinical and biomarker covariates was performed on a population-based study (N = 7766) stratified into three groups: low CRP—(LR; event rate 4.9%); low HDL-C/high CRP—(HR1; event rate 14.4%); and high HDL-C/high CRP—(HR2; event rate 7.6%). Modeling results for PON1 activity in HR2 were significant and robust (hazard ratio/SD unit—0.68, 95% CI 0.55–0.83, p = 0.0003), but not so for LR and HR1. Analyses in HR2 of the interaction of PON1 with HDL-C, apoA-I, apoA-II, and apoE levels were significant only for PON1 with apoE (hazard ratio—1.77, 95% CI 1.29–2.41, p = 0.0003). Subsequent subgroup analysis revealed inverse risk dependence for apoE at low PON1 levels. In conclusion, in a population-based study of subjects with concurrently high HDL-C and CRP levels, low serum PON1 activity associates with incident CVD risk with risk accentuated at low apoE levels. MDPI 2019-09-01 /pmc/articles/PMC6780415/ /pubmed/31480611 http://dx.doi.org/10.3390/jcm8091357 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Corsetti, James P. Sparks, Charles E. James, Richard W. Bakker, Stephan J. L. Dullaart, Robin P. F. Low Serum Paraoxonase-1 Activity Associates with Incident Cardiovascular Disease Risk in Subjects with Concurrently High Levels of High-Density Lipoprotein Cholesterol and C-Reactive Protein |
title | Low Serum Paraoxonase-1 Activity Associates with Incident Cardiovascular Disease Risk in Subjects with Concurrently High Levels of High-Density Lipoprotein Cholesterol and C-Reactive Protein |
title_full | Low Serum Paraoxonase-1 Activity Associates with Incident Cardiovascular Disease Risk in Subjects with Concurrently High Levels of High-Density Lipoprotein Cholesterol and C-Reactive Protein |
title_fullStr | Low Serum Paraoxonase-1 Activity Associates with Incident Cardiovascular Disease Risk in Subjects with Concurrently High Levels of High-Density Lipoprotein Cholesterol and C-Reactive Protein |
title_full_unstemmed | Low Serum Paraoxonase-1 Activity Associates with Incident Cardiovascular Disease Risk in Subjects with Concurrently High Levels of High-Density Lipoprotein Cholesterol and C-Reactive Protein |
title_short | Low Serum Paraoxonase-1 Activity Associates with Incident Cardiovascular Disease Risk in Subjects with Concurrently High Levels of High-Density Lipoprotein Cholesterol and C-Reactive Protein |
title_sort | low serum paraoxonase-1 activity associates with incident cardiovascular disease risk in subjects with concurrently high levels of high-density lipoprotein cholesterol and c-reactive protein |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780415/ https://www.ncbi.nlm.nih.gov/pubmed/31480611 http://dx.doi.org/10.3390/jcm8091357 |
work_keys_str_mv | AT corsettijamesp lowserumparaoxonase1activityassociateswithincidentcardiovasculardiseaseriskinsubjectswithconcurrentlyhighlevelsofhighdensitylipoproteincholesterolandcreactiveprotein AT sparkscharlese lowserumparaoxonase1activityassociateswithincidentcardiovasculardiseaseriskinsubjectswithconcurrentlyhighlevelsofhighdensitylipoproteincholesterolandcreactiveprotein AT jamesrichardw lowserumparaoxonase1activityassociateswithincidentcardiovasculardiseaseriskinsubjectswithconcurrentlyhighlevelsofhighdensitylipoproteincholesterolandcreactiveprotein AT bakkerstephanjl lowserumparaoxonase1activityassociateswithincidentcardiovasculardiseaseriskinsubjectswithconcurrentlyhighlevelsofhighdensitylipoproteincholesterolandcreactiveprotein AT dullaartrobinpf lowserumparaoxonase1activityassociateswithincidentcardiovasculardiseaseriskinsubjectswithconcurrentlyhighlevelsofhighdensitylipoproteincholesterolandcreactiveprotein |